UofL receives $6.1M in grants to research issues related to COVID-19
The University of Louisville has received millions in funding to research how lung issues in some COVID-19 patients become serious or even deadly.On Friday, it was announced the team of researchers received $5.8 million in two grants from the National Institutes of Health to expand their work to better understand and prevent immune system dysregulation responsible for acute respiratory distress, the condition responsible for serious illness and death in some COVID-19 patients. A separate $306,000 NIH Small Business Innovation Research grant supports early testing of a compound developed at UofL as a potential treatment. University of Louisville Immunologist Dr. Jun Yan has seen the impacts of COVID-19 firsthand.”The three NIH grants will provide vital resources to our team, which consists of scientists, researchers and public health professionals,” Yan told WLKY.Because of the partnership between UofL and UofL Health, they will work hand in hand.”This is what you dream of being able to do – these partnerships between research and clinical care when seeing a problem and finding a solution and taking that solution back to the patients,” said Dr. Jason Smith, the Chief Medical Officer at UofL Health.The hope is that more resources lead to better patient outcomes and a better understanding of the virus. It may not just benefit COVID-19 patients but those dealing with other types of viral and bacterial diseases. “We are confident that those studies will give valuable insight and breakthroughs empowering us to navigate the challenges that lie ahead,” said Yan.
LOUISVILLE, Ky. —
The University of Louisville has received millions in funding to research how lung issues in some COVID-19 patients become serious or even deadly.
On Friday, it was announced the team of researchers received $5.8 million in two grants from the National Institutes of Health to expand their work to better understand and prevent immune system dysregulation responsible for acute respiratory distress, the condition responsible for serious illness and death in some COVID-19 patients.
A separate $306,000 NIH Small Business Innovation Research grant supports early testing of a compound developed at UofL as a potential treatment.
University of Louisville Immunologist Dr. Jun Yan has seen the impacts of COVID-19 firsthand.
“The three NIH grants will provide vital resources to our team, which consists of scientists, researchers and public health professionals,” Yan told WLKY.
Because of the partnership between UofL and UofL Health, they will work hand in hand.
“This is what you dream of being able to do – these partnerships between research and clinical care when seeing a problem and finding a solution and taking that solution back to the patients,” said Dr. Jason Smith, the Chief Medical Officer at UofL Health.
The hope is that more resources lead to better patient outcomes and a better understanding of the virus. It may not just benefit COVID-19 patients but those dealing with other types of viral and bacterial diseases.
“We are confident that those studies will give valuable insight and breakthroughs empowering us to navigate the challenges that…
Read More: UofL receives $6.1M in grants to research issues related to COVID-19